Please login to the form below

Not currently logged in
Email:
Password:

Asian patient groups give pharma above average marks for reputation

PatientView survey finds 49% believe sector has a good corporate reputation

PatientViewAsian patient groups have an above average impression of pharmaceutical companies, according to a new report.

New data from PatientView’s established corporate reputation survey show 49% of patient groups in Asia believe the sector has an ‘excellent’ or ‘good’ corporate reputation.

The figures, drawn from 98 patient groups from Australasia, Central Asia, East Asia, South Asia and South-East Asia, present a rosier picture than their counterparts from around the world, 37% of which held the same view.

PatientView’s 2016 Corporate Reputation of Pharma Companies survey covers the efforts of 16 global pharma companies including Pfizer - which was ranked the most familiar to the Asian patient groups.

Respondents also ranked AbbVie as overall first for corporate reputation among the groups familiar with the firm. The US company ranked first for patient-centricity, transparency and patient-group relations as well.

Meanwhile, GSK was placed first for the provision of ‘high-quality’ patient information and Novo Nordisk took first position for patient safety, high quality products and integrity.

Article by
Gemma Jones

16th June 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Grabbing your audience*
Highlighting one of our recent pieces of work - a powerful disease awareness film created in partnership with Watchable Films...
Defining Market Access and the Key to Success
Kevin Lennon, Head of Operations & Market Access at OUTiCO, shares his definition of market access and the key to success....
the_other_side_of_multiple_sclerosis_thumb.jpg
THE OTHER SIDE OF … MULTIPLE SCLEROSIS
“My sister went without treatment despite relapses - enough was enough, I had to intervene”...

Infographics